Giulia Fulci
- Genetics top 2%
- Molecular Biology top 10%
- Oncology top 5%
- Epidemiology top 10%
- Immunology top 10%
- Co-authors
- E. Antonio ChioccaErwin G. Van MeirRalph WeisslederBalveen KaurDavide GianniJin WangJianjun Paul TianAvner Friedman
- Topics
- Virus-based gene therapy research (16 papers)CAR-T cell therapy research (10 papers)RNA Interference and Gene Delivery (5 papers)
- Cited by
- GeneticsOncologyBiotechnology
- Journals
- Proceedings of the National Academy of SciencesThe Journal of Experimental MedicineJournal of Clinical Oncology
- Partner nations
- United StatesNetherlandsChina
In The Last Decade
Giulia Fulci
36 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 90
- Genetics 1.0k
- Molecular Biology 898
- Oncology 857
- Epidemiology 272
- Immunology 263
Countries citing papers authored by Giulia Fulci
This map shows the geographic impact of Giulia Fulci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Fulci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Fulci more than expected).
Fields of papers citing papers by Giulia Fulci
This network shows the impact of papers produced by Giulia Fulci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Fulci. The network helps show where Giulia Fulci may publish in the future.
Co-authorship network of co-authors of Giulia Fulci
This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Fulci. A scholar is included among the top collaborators of Giulia Fulci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Fulci. Giulia Fulci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 8 | |
| 4 | 4 | |
| 5 | 34 | |
| 6 | 11 | |
| 7 | 59 | |
| 8 | 23 | |
| 9 | 29 | |
| 10 | 57 | |
| 11 | 135 | |
| 12 | 72 | |
| 13 | 50 | |
| 14 | 95 | |
| 15 | 30 | |
| 16 | 89 | |
| 17 | 113 | |
| 18 | 20 | |
| 19 | 69 | |
| 20 | Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha. | 64 |
About Giulia Fulci
Giulia Fulci is a scholar working on Oncology, Genetics and Hematology, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), CAR-T cell therapy research (10 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Genetics (1.0k citations), Oncology (857 citations) and Biotechnology (191 citations). Giulia Fulci has collaborated with scholars based in United States, Netherlands and China. Frequent co-authors include E. Antonio Chiocca, Erwin G. Van Meir, Ralph Weissleder, Balveen Kaur, Davide Gianni, Jin Wang, Jianjun Paul Tian, Avner Friedman, Hiroaki Wakimoto and Nobuaki Ishii. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.